Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1995-06-06
1998-03-24
Webman, Edward J.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424501, 424427, 514912, 514913, 514914, 514952, A61K 916, A61K 4742, A61K 4732, A61K 4736
Patent
active
057310050
ABSTRACT:
The present invention provides a sustained-release delivery composition for ophthalmic drugs comprising cross-linked hydrogel microspheres having a binding affinity for the drug.
REFERENCES:
patent: 3427301 (1969-02-01), Needles et al.
patent: 3469003 (1969-09-01), Haver-Lockart
patent: 3914402 (1975-10-01), Shell
patent: 4001388 (1977-01-01), Shell
patent: 4061787 (1977-12-01), Higgens
patent: 4115544 (1978-09-01), Shell
patent: 4138383 (1979-02-01), Rembaum et al.
patent: 4140537 (1979-02-01), Luck et al.
patent: 4221778 (1980-09-01), Raghunathan
patent: 4233360 (1980-11-01), Luck et al.
patent: 4280954 (1981-07-01), Yannas et al.
patent: 4294241 (1981-10-01), Miyata
patent: 4404033 (1983-09-01), Steffan et al.
patent: 4448718 (1984-05-01), Yannas et al.
patent: 4500453 (1985-02-01), Shank
patent: 4582640 (1986-04-01), Smestad et al.
patent: 4590020 (1986-05-01), Itaba et al.
patent: 4597762 (1986-07-01), Walter et al.
patent: 4703108 (1987-10-01), Silver et al.
patent: 4808399 (1989-02-01), Rypacek et al.
patent: 4824620 (1989-04-01), Casa et al.
patent: 4863647 (1989-09-01), Baylor et al.
patent: 4865846 (1989-09-01), Kaufman
patent: 4882150 (1989-11-01), Kaufman
patent: 4892700 (1990-01-01), Guerra et al.
patent: 4911920 (1990-03-01), Jani et al.
patent: 4923699 (1990-05-01), Kaufman
patent: 4923700 (1990-05-01), Kaufman
patent: 4948540 (1990-08-01), Nigam
patent: 4958008 (1990-09-01), Petite et al.
patent: 4969912 (1990-11-01), Kelman et al.
patent: 4970298 (1990-11-01), Silver et al.
patent: 4971954 (1990-11-01), Brodsky et al.
patent: 4981912 (1991-01-01), Kaisha
patent: 4996047 (1991-02-01), Keller
patent: 5024742 (1991-06-01), Nesburn et al.
patent: 5041292 (1991-08-01), Feijen
patent: 5093126 (1992-03-01), Jani et al.
patent: 5192535 (1993-03-01), Davis et al.
E. Balazs, D.B. Sweeny, A. McPherson (ed.); The Injection of Hyaluronic Acid and Reconstitued bitreous into the Vitreous Cavity; New and Controversial Aspects of Retinal Detachment ; 36:371-376 (1968).
M. Chvapil, R. Kronenthal, W. van Winkle; Medical and Surgical Applications of Collagen; Int. Rev. Conn. Tissues 6:1-61 (1973).
M. Chvapil, D. Speer, W. Mora, C. Eskelson; Effect of Tanning Agent on Tissue Reaction to Tissue Implanted Collagen Sponge; J. Surg. Res. 35:402-409 (1983).
M. Dunn, T. Miyata, K. Stnzel, A. Rubin; Studies on Collagen Implants in the Vitreous; Surgical Forum/Opthalmic Surgery , 19:492-494 (1968).
Z. Horakova et al.; Prolongation par les Substances Col lagenes de Quelques Actions Parmacologiques; Therapie 22:1455-1460 (1967).
S. Richard-Blum, G. Vile; Minireview: Collagen Crosslinking; Int. J. Biochem. 21(11): 1185-1189.
A. Rubin, K. Stenzel; Collagen as a Biomaterial; Technol. Rev. 71(2):44-49 (1968).
K. Weadock, R. Olson, F. Silver; evaluation of Collagen Crosslinking Techniques; Biomat. Med. Dev. Art. Org. 11(4):293-318 (1983-4).
Jungherr Lisa B.
Ottoboni Thomas B.
Yamamoto Ronald K.
Vitaphore Corporation
Webman Edward J.
LandOfFree
Hydrogel-based microsphere drug delivery systems does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrogel-based microsphere drug delivery systems, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrogel-based microsphere drug delivery systems will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2286867